These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Presynaptic dopamine receptors in the cardiovascular system.
    Author: Langer SZ, Vidal M, Duval N.
    Journal: Clin Exp Hypertens A; 1987; 9(5-6):837-51. PubMed ID: 3621629.
    Abstract:
    Stimulation by agonists of presynaptic dopamine receptors on nerve terminals of peripheral sympathetic neurons results in inhibition of norepinephrine release and a concomitant reduction of end organ responses to sympathetic nerve stimulation. These presynaptic dopamine receptors are of the DA-2 subtype and can be blocked selectively by the antagonist S-sulpiride. Presynaptic DA-2 receptors are the target of action of agonists with potential antihypertensive and bradycardic effects. Under control conditions exposure to S-sulpiride on its own does not enhance norepinephrine release. Following chronic treatment of cats with pargyline, S-sulpiride produced a small but significant increase in the electrically-evoked release of 3H-norepinephrine from perfused atrial slices. The possible involvement of peripheral presynaptic DA-2 receptors in the antihypertensive effects of monoamine oxidase inhibitors is discussed.
    [Abstract] [Full Text] [Related] [New Search]